Market Overview

Mid-Morning Market Update: Markets Mixed; Infineon To Buy Cypress Semiconductor For $10B

Share:

Following the market opening Monday, the Dow traded up 0.23 percent to 24872 while the NASDAQ fell 0.64 percent to 7,405. The S&P also rose, gaining 0.11 percent to 2,755.

Leading and Lagging Sectors

Materials shares rose 1 percent on Monday. Meanwhile, top gainers in the sector included DRDGOLD Limited (NYSE: DRD), up 11 percent, and Eldorado Gold Corporation (NYSE: EGO), up 12 percent.

In trading on Monday, communication services shares fell by 2.4 percent.

Top Headline

Within a week after rumors swirled of a potential sale, Cypress Semiconductor Corporation (NASDAQ: CY) confirmed it has agreed to be acquired by Infineon Technologies AG (OTC: IFNNY) for $23.85 per share in cash, translating to an enterprise value of 9 billion euros, or $10.05 billion.

The per share offer price represented a 46-percent premium to the 30-day volume-weighted average price for the period ending May 28, the day prior to the one when reports of a potential sale emerged.

Equities Trading UP

Genocea Biosciences, Inc. (NASDAQ: GNCA) shares shot up 63 percent to $9.12 after the company presented results from its ongoing Phase 1/2a trial for GEN-009, the company's lead neoantigen vaccine candidate, at ASCO 2019.

Shares of Cypress Semiconductor Corporation (NASDAQ: CY) got a boost, shooting up 24 percent to $22.09. Cypress Semiconductor confirmed it has agreed to be acquired by Infineon Technologies AG (OTC: IFNNY) for $23.85 per share in cash, translating to an enterprise value of 9 billion euros, or $10.05 billion.

EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) shares were also up, gaining 32 percent to $0.3323 after the company received FDA approval to initiate its photorefractive keratectomy pivotal study.

Equities Trading DOWN

DelMar Pharmaceuticals, Inc (NASDAQ: DMPI) shares tumbled 45 percent to $2.25 after the company announced a $3.6 million registered direct offering.

Shares of Aduro BioTech, Inc. (NASDAQ: ADRO) were down 21 percent to $2.5599. Aduro Biotech and Novartis presented results from ongoing Phase 1b study of STING agonist ADU-S100 (MIW815) in combination with anti-PD-1 monoclonal antibody spartalizumab (PDR001) in patients with advanced solid tumors or lymphomas at the ASCO 2019.

FTD Companies, Inc. (NASDAQ: FTD) was down, falling 72 percent to $0.215 after the company filed voluntary Chapter 11 petitions to facilitate the completion of strategic initiatives. The company will also be delisted from the Nasdaq..

Commodities

In commodity news, oil traded up 1.7 percent to $54.40, while gold traded up 0.9 percent to $1,322.90.

Silver traded up 1.2 percent Monday to $14.74, while copper rose 0.3 percent to $2.6475.

Euro zone

European shares were lower today. The eurozone’s STOXX 600 fell 0.3 percent, the Spanish Ibex Index fell 0.5 percent, while Italy’s FTSE MIB Index fell 0.2 percent. Meanwhile, the German DAX dropped 0.2 percent, and the French CAC 40 dropped 0.1 percent while UK shares fell 0.1 percent.

Economics

The final reading of manufacturing PMI is slipped to 50.5 for May, versus initial reading of 50.6.

The ISM manufacturing index fell to 52.1 in May, compared to 52.8 in April. However, economists were expecting a reading of 52.6.

U.S. construction spending was unchanged for April, versus economists’ expectations for a 0.3 percent rise .

The Treasury is set to auction 3-and 6-month bills at 11:30 a.m. ET.

St. Louis Federal Reserve Bank President James Bullard is set to speak at the Union League Club of Chicago at 1:25 p.m. ET.

San Francisco Federal Reserve Bank President Mary Daly will speak in Singapore at 9:45 p.m. ET.

Posted-In: Mid-Morning Market UpdateNews Eurozone Commodities Global Intraday Update Markets

 

Related Articles (CY + ADRO)

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Molina Healthcare Has More Than 40% Upside Potential, BMO Says In Upgrade

ISM Manufacturing PMI Preview: Stable At Moderate Expansion